# 60 Degrees Pharmaceuticals, Inc.: Form 8-K, filed Oct 6, 2026

- Company: [60 Degrees Pharmaceuticals, Inc.](/companies/sxtp.md) (CIK 1946563)
- Form: 8-K
- Filed: 2026-10-06
- Accepted by EDGAR: Oct 6, 2026, 07:45 ET
- Period: 2026-10-06
- Accession: 0001213900-26-106979
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1946563/000121390026106979/ea0307761-8k_60degrees.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1946563/000121390026106979/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1946563/000121390026106979/ea0307761-8k_60degrees.htm

Filed Oct 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-106979. Last ingested by Listed: Oct 27, 2026, 08:06 ET. No prices; not investment advice.